US Dollar vs Yen

登録して無料でリアルタイムの株価、インタラクティブチャート、ライブオプションフローなどを入手してください。

登録

ホーム
投資
株式
アメリカ
NASDAQ
XOMA Corporation (XOMAO)
XOMA Corporation (XOMAO) ニュース

XOMAO

XOMA (XOMAO)

XOMA Corporation

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:XOMAO

1 2 3 4 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/05/14	20 : 30	GlobeNewswire Inc.	XOMA to Present at H.C. Wainwright 2nd Annual Bioconnect Investor Conference at NASDAQ	NASDAQ:XOMAO	XOMA Corporation
2024/05/09	20 : 30	GlobeNewswire Inc.	XOMA Reports First Quarter 2024 Financial Results and Highlights Recent Activities	NASDAQ:XOMAO	XOMA Corporation
2024/04/30	20 : 30	GlobeNewswire Inc.	XOMA Adds Economic Interests in Three First-in-Category Assets to its Royalty and Milestone Portfolio Including XACIATO™ (clindamycin phosphate) Vaginal Gel 2%	NASDAQ:XOMAO	XOMA Corporation
2024/04/25	20 : 30	GlobeNewswire Inc.	XOMA Earns $9 Million Milestone as FDA Grants Accelerated Approval to Day One’s OJEMDATM (tovorafenib) for Relapsed or Refractory BRAF-altered Pediatric Low-Grade Glioma (pLGG)	NASDAQ:XOMAO	XOMA Corporation
2024/04/03	22 : 00	GlobeNewswire Inc.	XOMA Corporation Announces Closing of Tender Offer	NASDAQ:XOMAO	XOMA Corporation
2024/03/21	20 : 30	GlobeNewswire Inc.	XOMA Declares Quarterly Preferred Stock Dividends	NASDAQ:XOMAO	XOMA Corporation
2024/03/20	05 : 05	GlobeNewswire Inc.	XOMA Announces Calculation of Additional Price Per Share and Extension of Expiration Date for Tender Offer for Kinnate Biopharma Inc.	NASDAQ:XOMAO	XOMA Corporation
2024/03/08	21 : 30	GlobeNewswire Inc.	XOMA Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights Recent and Upcoming Events Expected to Drive Shareholder Value	NASDAQ:XOMAO	XOMA Corporation
2024/02/28	21 : 30	GlobeNewswire Inc.	XOMA to Present at Upcoming Investor Conferences in March	NASDAQ:XOMAO	XOMA Corporation
2024/02/16	22 : 00	GlobeNewswire Inc.	XOMA Enters into Agreement to Acquire Kinnate Biopharma for Between $2.3352 and $2.5879 in Cash Per Share Plus a Contingent Value Right	NASDAQ:XOMAO	XOMA Corporation
2024/01/18	22 : 30	GlobeNewswire Inc.	XOMA Expands its Commercial Royalty and Milestone Portfolio with DSUVIA® Acquisition	NASDAQ:XOMAO	XOMA Corporation
2024/01/12	06 : 05	GlobeNewswire Inc.	FDA Acceptance of Zevra’s Arimoclomol NDA Filing for Niemann-Pick Disease Type C (NPC) Results in XOMA Making a $1 Million Milestone Payment to LadRx	NASDAQ:XOMAO	XOMA Corporation
2024/01/08	21 : 30	GlobeNewswire Inc.	XOMA Names Owen Hughes as Chief Executive Officer and Appoints Jack L. Wyszomierski as Chairman of the Board of Directors	NASDAQ:XOMAO	XOMA Corporation
2024/01/02	21 : 30	GlobeNewswire Inc.	XOMA Announces Stock Repurchase Program of up to $50 Million	NASDAQ:XOMAO	XOMA Corporation
2023/12/20	21 : 30	GlobeNewswire Inc.	XOMA Declares Quarterly Preferred Stock Dividends	NASDAQ:XOMAO	XOMA Corporation
2023/12/19	21 : 30	GlobeNewswire Inc.	XOMA Raises up to $140 Million in Non-Dilutive, Non-Recourse Financing from Funds Managed by Blue Owl Capital Backed by VABYSMO® Royalties	NASDAQ:XOMAO	XOMA Corporation
2023/11/07	21 : 30	GlobeNewswire Inc.	XOMA Reports Third Quarter 2023 Financial Results and Highlights Upcoming Events Expected to Drive Shareholder Value	NASDAQ:XOMAO	XOMA Corporation
2023/10/31	20 : 30	GlobeNewswire Inc.	XOMA Earns $5 Million Milestone Upon FDA Acceptance of Day One’s Tovorafenib NDA for Relapsed or Progressive Pediatric Low-Grade Glioma (pLGG)	NASDAQ:XOMAO	XOMA Corporation
2023/09/25	20 : 30	GlobeNewswire Inc.	XOMA Declares Quarterly Preferred Stock Dividends	NASDAQ:XOMAO	XOMA Corporation
2023/09/06	20 : 30	GlobeNewswire Inc.	XOMA to Present at H.C. Wainwright 25th Annual Global Investment Conference	NASDAQ:XOMAO	XOMA Corporation
2023/08/08	20 : 30	GlobeNewswire Inc.	XOMA Reports Second Quarter 2023 Financial Results and Provides Update on its Royalty Monetization Strategy	NASDAQ:XOMAO	XOMA Corporation
2023/06/24	07 : 14	GlobeNewswire Inc.	XOMA Added to the Russell 2000® and Russell 3000® Indexes	NASDAQ:XOMAO	XOMA Corporation
2023/06/22	20 : 30	GlobeNewswire Inc.	XOMA Acquires Royalty and Milestone Economics to Phase 3 First-In-Class Orphan Disease Asset for Niemann-Pick Disease Type C (NPC) and Phase 2 Oncology Asset	NASDAQ:XOMAO	XOMA Corporation
2023/06/20	20 : 30	GlobeNewswire Inc.	XOMA Declares Quarterly Preferred Stock Dividends	NASDAQ:XOMAO	XOMA Corporation
2023/05/26	05 : 34	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:XOMAO	XOMA Corporation
2023/05/23	05 : 31	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:XOMAO	XOMA Corporation
2023/05/23	05 : 31	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:XOMAO	XOMA Corporation
2023/05/20	06 : 04	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:XOMAO	XOMA Corporation
2023/05/20	05 : 32	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:XOMAO	XOMA Corporation
2023/05/20	05 : 31	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:XOMAO	XOMA Corporation

Showing the most relevant articles for your search:NASDAQ:XOMAO

1 2 3 4 次へ >>

Banque Federative du Cre...

So_stoxx50_mf61

NLBNPIT1TSK2 20240620 17...

Hsbc Usa Inc Itm Digital...

NLBNPIT212U4 20991231 23...

Coe Fx 28% Mar27 Try

Inav Db Xtrackers S&P 50...

NLBNPIT1ZR77 20241220 50

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約